BAI1 Antibody (480912) [PE]

• Applications: Flow, CyTOF-ready
• Clone: 480912
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: PE

BAI1 Antibody (480912) [PE] Summary

• Immunogen: HEK293 human embryonic kidney cell line transfected with human BAI1
  Ala31-Thr879
  Accession # O14514
• Specificity: Detects human BAI1 in direct ELISAs.
• Source: N/A
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein A or G purified from hybridoma culture supernatant
• Purity Statement: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: PBS
• Preservative: 0.05% Sodium Azide
• Purity: Protein A or G purified from hybridoma culture supernatant
• Reconstitution Instructions: Reconstitution default not known

Background

Brain Angiogenesis Inhibitor 1 (BAI1) is a 170 kDa 7-transmembrane domain G protein-coupled receptor (GPCR) that has a large N-terminal extracellular region with an RGD motif, five thrombospondin type I repeats, and a juxtamembrane GPS (GPCR proteolytic cleavage site) (1). Within the extracellular domain (ECD) up to the GPS (amino acids 31‑879), mature human BAI1 shares 94% amino acid sequence identity with mouse and rat BAI1. BAI1 is preferentially expressed on brain neurons but also is found on astrocytes and macrophages and in the pancreas, stomach, and colon (1‑8). BAI1 can be cleaved within the GPS to release a 120 kDa fragment termed Vasculostatin which corresponds to nearly the entire N-terminal ECD (9). Generation of additional soluble fragments suggests the cleavage of BAI1 at multiple sites (9, 10). BAI1 fragments interact with Integrin alpha V beta 5 or CD36 on microvascular endothelial cells to inhibit cell proliferation and migration (10, 11). Overexpression of BAI1 in glioblastoma or pancreatic adenocarcinoma cells inhibits their tumorigenicity and the development of tumor-associated neovascularization (6, 12). Fragments of the ECD, including Vasculostatin, also suppress in vivo angiogenesis and tumor growth (1, 9, 11). BAI1 is down‑regulated in glioblastoma, carcinomas of the pancreas, colon, and stomach and also in experimental ischemia (2, 4, 6‑8). Its expression is inversely correlated with tumor vascularity in colorectal and pulmonary carcinomas (8, 13). On macrophages and astrocytes, BAI1 mediates the phagocytosis of apoptotic cells through recognition of cell surface phosphatidylserine (5).

1. Nishimori, H. et al. (1997) Oncogene 15:2145.
2. Koh, J.T. et al. (2001) Brain Res. Mol. Brain Res. 87:223.
3. Mori, K. et al. (2002) Neurosci. Res. 43:69.
4. Kaur, B. et al. (2003) Am. J. Pathol. 162:19.
5. Park, D. et al. (2007) Nature 450:430.
6. Duda, D.G. et al. (2002) Br. J. Cancer 86:490.
7. Lee, J.H. et al. (2001) Int. J. Oncol. 18:355.
8. Fukushima, Y. et al. (1998) Int. J. Oncol. 13:967.
9. Kaur, B. et al. (2005) Oncogene 24:3632.
10. Koh, J.T. et al. (2004) Exp. Cell Res. 294:172.
11. Kaur, B. et al. (2009) Cancer Res. 69:1212.
12. Kang, X. et al. (2006) Cancer Gene Ther. 13:385.
13. Hatanaka, H. et al. (2000) Int. J. Mol. Med. 5:181.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.